Drugs / apricoxib
Trials 9 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00569114 | Oct 2007 → Apr 2009 | non-small cell lung carcinoma | Tragara Pharmaceuticals, Inc. | Completed | No outcome recorded |
| Phase 1/22 trials | ||||||
| Phase 1/2 | NCT05841550 | May 2023 → May 2027 expected | smoldering plasma cell myeloma | Oslo University Hospital | Recruiting | No outcome recorded |
| Phase 1/2 | NCT02261714 | Dec 2012 → May 2019 | pancreatic adenocarcinoma | Targovax ASA | Completed | No outcome recorded |
| Phase 25 trials | ||||||
| Phase 2 | NCT05638698 | Dec 2022 → Dec 2024 overdue | neoplasm | University of Kansas Medical Center | Active not recruiting | No outcome recorded |
| Phase 2 | NCT00771953 | Nov 2008 → May 2012 | non-small cell lung carcinoma | University of Maryland, Baltimore | Completed | No outcome recorded |
| Phase 2 | NCT00709826 | Aug 2008 → Jun 2010 | malignant pancreatic neoplasm | Tragara Pharmaceuticals, Inc. | Completed | No outcome recorded |
| Phase 2 | NCT00657137 | Apr 2008 → Sep 2009 | breast cancer | Tragara Pharmaceuticals, Inc. | Terminated | No outcome recorded |
| Phase 2 | NCT00652340 | Apr 2008 → Jun 2010 | non-small cell lung carcinoma | Tragara Pharmaceuticals, Inc. | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT01532362 | Nov 2011 → May 2012 | non-small cell lung carcinoma | Jonsson Comprehensive Cancer Center | Terminated | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 11 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | apricoxib | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00657137 ↗ |
| Known as | CS-706 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1835207 ↗ |
| Known as | R-109339 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1835207 ↗ |
| Known as | TG01 | “Drug: TG01” NCT00569114 ↗ |
| Action | Inhibit | “apricoxib, a novel COX-2 inhibitor” PMID 24736085 ↗ Apr 20141“Cyclooxygenase-2 inhibitor” CHEMBL1835207 ↗ |
| Modality | Small molecule | — CHEMBL1835207 ↗ |
| Modality | Vaccine | “TG01 vaccine” NCT05638698 ↗ |
| Route | Oral | “given orally” NCT00569114 ↗ |
| Target | PTGS2 | “Cyclooxygenase-2 inhibitor” CHEMBL1835207 ↗ |